Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab

Part of paid clinical trials in Bakersfield, California.

Sponsor
California Retina Consultants
Study ID
NCT02107131
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Performance assessment testing may be a useful tool to evaluate the impact of ranibizumab on day-to-day visual function in patients with Diabetic Macular Edema (DME).

Key Dates

First listed
Apr 8, 2014
Start date
Mar 13, 2015
Status verified
Nov 2018
Primary completion
May 15, 2017
Completion
May 15, 2017

Study Design

Enrollment
40 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Monthly Intravitreal ranibizumab 0.3mg
    Monthly Intravitreal ranibizumab 0.3mg injections.
  • Active Comparator: PRN Intravitreal ranibizumab 0.3mg
    PRN Intravitreal ranibizumab 0.3mg injections.

Primary Outcome Measure

A Change Between Two Time Points is Reported for Maximum Reading Speed [ Time Frame: Month 12 ]

Locations (6)

FacilityCityStateZIPSite coordinators
California Retina Consultants - BakersfieldBakersfieldCalifornia93039-
California Retina ConsultantsOxnardCalifornia93454-
California Retina ConsultantsPalmdaleCalifornia93551-
California Retina Consultants - Santa Barbara OfficeSanta BarbaraCalifornia93103-
California Retina ConsultantsSanta MariaCalifornia93454-
California Retina ConsultantsVisaliaCalifornia93277-

Find similar trials in Bakersfield, CA

By condition
Diabetic retinopathy
By specialty
OphthalmologyRetina
By research site
California Retina Consultants - Bakersfield· Bakersfield, CACalifornia Retina Consultants· Oxnard, CACalifornia Retina Consultants· Palmdale, CACalifornia Retina Consultants - Santa Barbara Office· Santa Barbara, CACalifornia Retina Consultants· Santa Maria, CACalifornia Retina Consultants· Visalia, CA

Related Studies